Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Return on Sales (2018 - 2025)

AVITA Medical's Return on Sales history spans 8 years, with the latest figure at 0.13% for Q4 2025.

  • For Q4 2025, Return on Sales fell 285.0% year-over-year to 0.13%; the TTM value through Dec 2025 reached 0.33%, down 33.0%, while the annual FY2025 figure was 0.68%, 68.0% down from the prior year.
  • Return on Sales reached 0.13% in Q4 2025 per RCEL's latest filing, up from 0.78% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 2.73% in Q4 2024 to a low of 1.68% in Q1 2024.
  • Average Return on Sales over 5 years is 0.43%, with a median of 0.72% recorded in 2021.
  • Peak YoY movement for Return on Sales: skyrocketed 323bps in 2023, then plummeted -285bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.64% in 2021, then increased by 9bps to 0.58% in 2022, then skyrocketed by 557bps to 2.65% in 2023, then rose by 3bps to 2.73% in 2024, then crashed by -105bps to 0.13% in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Return on Sales are 0.13% (Q4 2025), 0.78% (Q3 2025), and 0.54% (Q2 2025).